ELV vs STRO · P/E 18, rev $199.13B vs rev $62.0M
Elevance Health Inc (ELV) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ELV and STRO stock pages for the full models.
Not investment advice.